REGULATED PRESS RELEASE published on 11/07/2024 at 18:36, 1 year 6 months ago I.CERAM - Professor Pascal Leprince, Head of the Cardiac Surgery Department at the Pitié-Salpêtrière Hospital in Paris, has agreed to set up a pilot clinical I.Ceram to conduct pilot clinical study on antibiotic-loaded Porous Ceramic Sternal Stabilisation Implant at Pitié-Salpêtrière Hospital in Paris with Professor Pascal Leprince. Implant aims to prevent bacterial contamination and stabilize chest walls I.Ceram Clinical Study Antibiotic-loaded Implant Porous Ceramic Chest Wall Stabilization
PRESS RELEASE published on 11/07/2024 at 18:30, 1 year 6 months ago Réalisation de l'apport partiel d'actif de MammoRisk à une valorisation de 202 M EUR Predilife annonce la réalisation de l'apport partiel d'actif de MammoRisk à une valorisation de 202 M€ pour favoriser son développement international. Création de valeur et partenariats en vue Développement International Valorisation PREDILIFE MammoRisk Apport Partiel D'actif
PRESS RELEASE published on 11/07/2024 at 18:30, 1 year 6 months ago Epique Realty Hosts Exclusive Leadership Event Margaritaville Resort Orlando Epique Realty hosts a leadership event at Margaritaville Resort in Orlando, uniting leaders for growth, inspiration, and celebration. Renowned speakers, valuable insights, and a day of fun at Disney's Epcot Real Estate Industry Epique Realty Leadership Event Learning Opportunities Disney's Epcot
PRESS RELEASE published on 11/07/2024 at 18:30, 1 year 6 months ago Continued hypergrowth in monthly recurring revenue and targets confirmed WALLIX reports 23.7% MRR growth in Sept. 2024, reaffirms financial targets for 2024. Recurring business expanded 12.5%, aiming for operating profit in 2024 and 2025 Operating Profit Financial Targets WALLIX Recurring Business MRR Growth
PRESS RELEASE published on 11/07/2024 at 18:30, 1 year 6 months ago Poursuite de l'hyper croissance du revenu mensuel récurrent et confirmation des objectifs WALLIX annonce une croissance de +23,7% de son MRR au 30 septembre 2024 et confirme ses objectifs financiers. Les revenus récurrents représentent 73,5% du CA consolidé en 2024 Croissance Revenus Récurrents Cybersécurité Objectifs Financiers WALLIX
REGULATED PRESS RELEASE published on 11/07/2024 at 18:11, 1 year 6 months ago LNA SANTE : Q3 2024 LNA Santé reports solid growth in operating revenue and activities for the first 9 months of 2024, with dynamic business lines and high occupancy rates. Adjusted organic growth target for 2024: +5% LNA Santé Organic Growth Business Lines Operating Revenue Occupancy Rates
REGULATED PRESS RELEASE published on 11/07/2024 at 18:10, 1 year 6 months ago I.CERAM - Le Professeur Pascal Leprince, Chef du service de chirurgie cardiaque de l’hôpital de la Pitié-Salpêtrière à Paris, donne son accord pour la mise en place d’une étude clinique pilote Le Professeur Pascal Leprince de l'hôpital de la Pitié-Salpêtrière à Paris lance une étude clinique pilote sur l'Implant de Stabilisation Sternale en Céramique poreuse chargé en antibiotiques avec I.CERAM I.Ceram Implant Céramique Étude Clinique Chirurgie Cardiaque Antibiotiques
PRESS RELEASE published on 11/07/2024 at 18:06, 1 year 6 months ago Edison issues report on HgT (HGT) Edison issues report on HgT (HGT) revealing strong earnings momentum and NAV performance despite adverse currency movements, achieving 5.5% YTD NAV TR NAV Performance Edison HgT Earnings Momentum Currency Movements
REGULATED PRESS RELEASE published on 11/07/2024 at 18:04, 1 year 6 months ago LNA SANTE : Chiffre d'affaires du 3ème trimestre 2024 Communiqué de Presse - LNA Santé affiche une croissance solide et régulière de son activité en 2024. Objectif de croissance organique corrigée de +5%. Taux d'occupation élevé et développement des activités à domicile. Préparation des prochaines cessions immobilières Croissance LNA Santé Taux D'occupation Activité Cession Immobilière
PRESS RELEASE published on 11/07/2024 at 18:01, 1 year 6 months ago freenet continues successful development in 2024 – performance allows for specification and partial increase of 2024 financial guidance freenet AG reports successful performance in 2024 with revenue growth and raised financial guidance. Key figures show moderate growth in revenues and narrowed EBITDA and free cash flow guidance EBITDA Revenue Growth Financial Guidance 2024 Freenet AG
Published on 05/09/2026 at 01:30, 1 day 7 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 9 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/09/2026 at 19:05, 13 hours 59 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 12 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 13 hours ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 14 hours ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 2 days 13 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 13 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 13 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 13 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 14 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL